AI cancer cures slowed by chip shortage, says UK's biggest tech boss
The head of chip designer Arm says modelling how a DNA marker is impacted by cancer cannot be done now, but computers are "going to solve it".
Rene Haas, chief executive of Arm Holdings, a major UK-based tech firm, has stated that artificial intelligence (AI) will eventually discover a cure for cancer that humans currently cannot within our lifetimes. While modeling a DNA marker's impact on cancer is currently too complex for humans and computers, Haas believes AI will soon overcome this challenge as the models become more sophisticated.
Haas also predicted that within the next five years, AI would lead to the widespread use of humanoid robots in various industries, such as manufacturing, cleaning, and security. However, he argued that the rapid growth of AI is currently being held back by a shortage of chips needed to build data centers. Although he expressed skepticism about the UK manufacturing chips in the future, Haas highlighted that Arm's power-efficient technology is now used in half of AI data centers worldwide, leading to significant growth in its business recently.
Meta, a Facebook owner, had placed a large demand for Arm's AGI chip, resulting in over $2 billion worth of orders since its launch in March.
Written by urgent.news from BBC World's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
